Stay updated on Sorafenib Nivolumab in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Sorafenib Nivolumab in Liver Cancer Clinical Trial page.

Latest updates to the Sorafenib Nivolumab in Liver Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision: v3.4.2 was added. The funding-status notice about a lapse in government funding and the Revision: v3.4.1 notice were removed.SummaryDifference0.4%

- Check15 days agoChange DetectedAdded a site-wide government funding/status notice and updated the page revision to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.4%

- Check22 days agoChange DetectedShow glossary has been added; the page now displays 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0' metadata, while the previous 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' labels were removed.SummaryDifference0.2%

- Check36 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed.SummaryDifference0.0%

- Check57 days agoChange DetectedAdded a Locations section with California locations; removed the California Locations header. Revision updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check86 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing the previous v3.2.0. No study details or eligibility information appear to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Sorafenib Nivolumab in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sorafenib Nivolumab in Liver Cancer Clinical Trial page.